{"disease":{"id":"allergic-fungal-rhinosinusitis","name":"allergic fungal rhinosinusitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06376071","title":"Sinonasal Risk Factors for Occurrence of Unilateral Versus Bilateral Allergic Fungal Rhinosinusitis .","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":76,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04684524","title":"Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT05545072","title":"Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Emory University","has_results":true},{"nct_id":"NCT06461949","title":"Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Institute on Deafness and Other Communication Disorders (NIDCD)","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}